Home › NCT07391410

Registry for Bone Metastases

RecruitingObservational study

The International Bone Metastasis Registry

Who can join

Ages 22 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

* Age ≥22 years
* Biopsy-proven or clinically obvious metastatic bone disease . For purposes of this study, metastatic bone disease includes skeletal involvement from multiple myeloma.
* Symptomatic bone lesion requiring intervention
* This includes but is not limited to radiotherapy, cryotherapy, radiofrequency ablation, operative fixation, prosthetic replacement, amputation, or any combination of the above

Exclusion Criteria:

* Age \<22 years

About the study

The purpose of this study is to learn more about symptomatic bone metastases. This study is an international patient registry of people with symptomatic bone metastases. A patient registry is a database - a collection of health information - about a group of people, and it is usually focused on a specific diagnosis or condition.

Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 500 · Started: Jan 13, 2026

Contact the study team

Jonathan Forsberg, MD, PhD · Phone: 212-639-2076
Carol Morris, MD · Phone: 212-639-7611

Official record on ClinicalTrials.gov — NCT07391410

Locations in the U.S.

New Jersey	Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
New York	Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.